Moreover, on account of the success of these glutamine analogs in vitro, the inhibitors of GFAT1 were found to be effective in reducing tumor burden in soft tissue sarcoma, bone sarcoma, mesothelioma and colorectal carcinoma patients22, 23. The gene discussed is GFPT1; the disease is neoplasm.